Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that senior management team of Suven Life Sciences is giving corporate presentation in 'ICICI Securities' Annual Investor Conference 2019' with fund managers and analysts meet organized in Singapore on 11th - 12th Feb and Hong Kong on 13th - 14th Feb 2019 by ICICI Securities. Please find enclosed Corporate Presentation. Suven Life Sciences Ltd - 530239 - Outcome of Board Meeting
This is to inform you that the Board of Directors of the Company at their meetings held on 5th February 2019 approved the following: The Company has acquired all the shares of Suven Pharmaceuticals Limited ('SPL'), a public limited company, from its existing shareholders. Pursuant to which, Suven Pharmaceuticals Limited has become a wholly owned subsidiary of the Company. The Board also approved draft Scheme of Arrangement to be filed at the National Company Law Tribunal bench at Hyderabad, for necessary approvals. Suven Life Sciences Ltd - 530239 - Board declares Interim Dividend
Suven Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 05, 2019, inter alia, has declared an interim dividend of Rs. 1.50 per equity share of face value Rs. 1/- each for the year 2018-2019.The above said dividend will be paid on and from February 25, 2019. Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached Investor Presentation Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Date of payment of Dividend
Interim Dividend a) The Board declared an interim dividend of Rs. 1.50 per equity share of face value Rs 1/- each for the year 2018-2019. b) The Board approved the Record Date i.e., 15th February 2019 notified by the Company for the purpose of payment of interim dividend to the eligible shareholders. c) The above said dividend will be paid on and from 25th February, 2019. Suven Life Sciences Ltd - 530239 - Outcome Of The Board Meeting
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 5th February, 2019, has taken on record the Un-audited Financial Results of the Company under Ind AS for the quarter and nine months ended 31st December, 2018 and approved the following matters. Suven Life Sciences Ltd - 530239 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Suven Life Sciences Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate. Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Wednesday, February 06, 2019 at 12:30 p.m. IST to discuss the Un-audited Financial Results for the Q3&9M Financial Year 2019, to be declared on 05th February, 2019 Suven Life Sciences Ltd - 530239 - Fixes Record Date for Interim Dividend
Suven Life Sciences Ltd has informed BSE that the Company has fixed February 15, 2019 as the Record Date for the purpose of Payment of Interim Dividend, if any. SUVEN LIFE SCIENCES LTD. - 530239 - Board to consider Interim Dividend
Suven Life Sciences Ltd has informed BSE that a Meeting of Board of Directors of the Company will be held on February 05, 2019, inter alia, to consider and take on record the following matter(s):1. To consider and approve the Un-audited Financial Results of the Company under Ind AS for the quarter and nine months ended December 31, 2018.2. To consider declaration of Interim Dividend, if any, for the financial year 2018-19 and related matters etc. Further, the TRADING WINDOW for dealing in the securities of the company is closed from January 28, 2019 to February 08, 2019 (both days inclusive) as per PIT Code of the Company. Trading window will be opened from February 09, 2019.